FDA approves Emergent BioSolutions' inhaled anthrax treatment

Emergent BioSolutions Inc said the U.S. Food and Drug Administration approved its treatment for inhaled anthrax, triggering a $ 7 million milestone payment from the Department of Health and Human Services (HHS). The company developed the treatment, Anthrasil, as part of a $ 160 million contract it signed in 2005 with the Biomedical Advanced Research and Development Authority (BARDA), a part of the …
FDA News – Yahoo News Search Results

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us